Hypofractionated Radiation Therapy Suppresses Radioresistance in U87 Human Glioma Cells by Inhibiting Yap1 and Hsp90 Proteins

Current Radiopharmaceuticals · Published 2024-04-30 · DOI 10.2174/0118744710300495240409074900

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0118744710300495240409074900

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Identification of TNFRSF12A as a key regulator of stemness and immunosuppression in a novel glioma subtype via multi-omics analysis and experimental validation · Clinical Immunology · 2026 · Cites or is cited by this article
• RNA Binding Proteins are Pivotal Regulators of Cancer Radioresistance and Potential Targets for Preventing Tumor Recurrence · Current Radiopharmaceuticals · 2025 · Same journal
• Analysis of set-up errors in daily kilovolt fan beam CT for rectal cancer treated with volumetric modulated arc therapy · Current Radiopharmaceuticals · 2025 · Same journal
• Anatomy as a guide: Using learned priors for precise organ segmentation · Current Radiopharmaceuticals · 2026 · Same journal
• Comparative dosimetric analysis of hippocampal-sparing vs conventional craniospinal irradiation in central nervous system leukemia: A single-center study · Current Radiopharmaceuticals · 2025 · Same journal
• EAVS-TF: A bio-inspired spiking neural network for energy-efficient multimodal emotion recognition · Current Radiopharmaceuticals · 2026 · Same journal
• Preclinical Aspects of [89Zr]Zr-DFO-Rituximab: A High Potential Agent for Immuno-PET Imaging · Current Radiopharmaceuticals · 2024 · Same journal
• Radioprotective effects of curcumin during radiotherapy: Critical evaluation of preclinical and clinical evidence · Current Radiopharmaceuticals · 2026 · Same journal
• Enhancing Ketoprofen Solubility: A Strategic Approach Using Solid Dispersion and Response Surface Methodology · Current Radiopharmaceuticals · 2024 · Same journal
• The role of 131I in the treatment and management of thyroid cancer · Current Radiopharmaceuticals · 2025 · Same journal